{"id":356,"date":"2019-10-28T15:42:04","date_gmt":"2019-10-28T15:42:04","guid":{"rendered":"https:\/\/www.octagamus.net\/dermotymositis\/?page_id=356"},"modified":"2024-03-13T17:50:59","modified_gmt":"2024-03-13T17:50:59","slug":"efficacy-adults","status":"publish","type":"page","link":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/","title":{"rendered":"Improvement in TIS & Disease Severity"},"content":{"rendered":"\n

PRIMARY ENDPOINT – TIS Responder Rate1-3<\/sup><\/h2>\n

Significantly more patients treated with octagam 10% achieved a TIS response* at Week 16 vs placebo<\/h3>\n

The efficacy of octagam 10% in patients with DM was confirmed, with the primary endpoint met. There was a higher proportion of responders at 16 weeks in the octagam 10% group than in the placebo group (78.7% vs 43.8%) and the difference in response rates was statistically significant: 34.97% (95% CI: 16.70, 53.24; p=0.0008).<\/p>\n

\"\"<\/p>\n\n","protected":false},"excerpt":{"rendered":"

PRIMARY ENDPOINT – TIS Responder Rate1-3 Significantly more patients treated with octagam 10% achieved a TIS response* at Week 16…<\/p>\n","protected":false},"author":17,"featured_media":505,"parent":357,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-356","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nOctagam 10% Efficacy - Dermatomyositis Study Results<\/title>\n<meta name=\"description\" content=\"Explore the efficacy of Octagam 10% (Immune Globulin Intravenous [Human] 10% Liquid Preparation) in treating dermatomyositis in adults. Access Important Safety Information, including essential boxed warnings, for a comprehensive understanding of its effectiveness and safety profile.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Octagam 10% Efficacy - Dermatomyositis Study Results\" \/>\n<meta property=\"og:description\" content=\"Explore the efficacy of Octagam 10% (Immune Globulin Intravenous [Human] 10% Liquid Preparation) in treating dermatomyositis in adults. Access Important Safety Information, including essential boxed warnings, for a comprehensive understanding of its effectiveness and safety profile.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/\" \/>\n<meta property=\"og:site_name\" content=\"Octagam 10% Dermatomyositis\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-13T17:50:59+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/octagamusa.com\/dermatomyositis\/wp-content\/uploads\/sites\/4\/2021\/10\/ProDERM_Icon.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1623\" \/>\n\t<meta property=\"og:image:height\" content=\"1622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/efficacy-adults\\\/\",\"url\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/efficacy-adults\\\/\",\"name\":\"Octagam 10% Efficacy - Dermatomyositis Study Results\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/efficacy-adults\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/efficacy-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2021\\\/10\\\/ProDERM_Icon.png\",\"datePublished\":\"2019-10-28T15:42:04+00:00\",\"dateModified\":\"2024-03-13T17:50:59+00:00\",\"description\":\"Explore the efficacy of Octagam 10% (Immune Globulin Intravenous [Human] 10% Liquid Preparation) in treating dermatomyositis in adults. Access Important Safety Information, including essential boxed warnings, for a comprehensive understanding of its effectiveness and safety profile.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/efficacy-adults\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/efficacy-adults\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/efficacy-adults\\\/#primaryimage\",\"url\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2021\\\/10\\\/ProDERM_Icon.png\",\"contentUrl\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2021\\\/10\\\/ProDERM_Icon.png\",\"width\":1623,\"height\":1622},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/efficacy-adults\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evidence\",\"item\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/hcp\\\/fda-approved-ivig-therapy\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Improvement in TIS & Disease Severity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/#website\",\"url\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/\",\"name\":\"Octagam 10% Dermatomyositis\",\"description\":\"Dermatomytositis (DM) in Adults\",\"publisher\":{\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/#organization\",\"name\":\"Octagam (Immune Globulin Intravenous [Human] 10% Liquid Preparation)\",\"url\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2022\\\/05\\\/SocialShare_1200x630_10.jpg\",\"contentUrl\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2022\\\/05\\\/SocialShare_1200x630_10.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Octagam (Immune Globulin Intravenous [Human] 10% Liquid Preparation)\"},\"image\":{\"@id\":\"https:\\\/\\\/octagamusa.com\\\/dermatomyositis\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Octagam 10% Efficacy - Dermatomyositis Study Results","description":"Explore the efficacy of Octagam 10% (Immune Globulin Intravenous [Human] 10% Liquid Preparation) in treating dermatomyositis in adults. Access Important Safety Information, including essential boxed warnings, for a comprehensive understanding of its effectiveness and safety profile.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/","og_locale":"en_US","og_type":"article","og_title":"Octagam 10% Efficacy - Dermatomyositis Study Results","og_description":"Explore the efficacy of Octagam 10% (Immune Globulin Intravenous [Human] 10% Liquid Preparation) in treating dermatomyositis in adults. Access Important Safety Information, including essential boxed warnings, for a comprehensive understanding of its effectiveness and safety profile.","og_url":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/","og_site_name":"Octagam 10% Dermatomyositis","article_modified_time":"2024-03-13T17:50:59+00:00","og_image":[{"width":1623,"height":1622,"url":"http:\/\/octagamusa.com\/dermatomyositis\/wp-content\/uploads\/sites\/4\/2021\/10\/ProDERM_Icon.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/","url":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/","name":"Octagam 10% Efficacy - Dermatomyositis Study Results","isPartOf":{"@id":"https:\/\/octagamusa.com\/dermatomyositis\/#website"},"primaryImageOfPage":{"@id":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/#primaryimage"},"image":{"@id":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/octagamusa.com\/dermatomyositis\/wp-content\/uploads\/sites\/4\/2021\/10\/ProDERM_Icon.png","datePublished":"2019-10-28T15:42:04+00:00","dateModified":"2024-03-13T17:50:59+00:00","description":"Explore the efficacy of Octagam 10% (Immune Globulin Intravenous [Human] 10% Liquid Preparation) in treating dermatomyositis in adults. Access Important Safety Information, including essential boxed warnings, for a comprehensive understanding of its effectiveness and safety profile.","breadcrumb":{"@id":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/#primaryimage","url":"https:\/\/octagamusa.com\/dermatomyositis\/wp-content\/uploads\/sites\/4\/2021\/10\/ProDERM_Icon.png","contentUrl":"https:\/\/octagamusa.com\/dermatomyositis\/wp-content\/uploads\/sites\/4\/2021\/10\/ProDERM_Icon.png","width":1623,"height":1622},{"@type":"BreadcrumbList","@id":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/efficacy-adults\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/"},{"@type":"ListItem","position":2,"name":"Evidence","item":"https:\/\/octagamusa.com\/dermatomyositis\/hcp\/fda-approved-ivig-therapy\/"},{"@type":"ListItem","position":3,"name":"Improvement in TIS & Disease Severity"}]},{"@type":"WebSite","@id":"https:\/\/octagamusa.com\/dermatomyositis\/#website","url":"https:\/\/octagamusa.com\/dermatomyositis\/","name":"Octagam 10% Dermatomyositis","description":"Dermatomytositis (DM) in Adults","publisher":{"@id":"https:\/\/octagamusa.com\/dermatomyositis\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/octagamusa.com\/dermatomyositis\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/octagamusa.com\/dermatomyositis\/#organization","name":"Octagam (Immune Globulin Intravenous [Human] 10% Liquid Preparation)","url":"https:\/\/octagamusa.com\/dermatomyositis\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/octagamusa.com\/dermatomyositis\/#\/schema\/logo\/image\/","url":"https:\/\/octagamusa.com\/dermatomyositis\/wp-content\/uploads\/sites\/4\/2022\/05\/SocialShare_1200x630_10.jpg","contentUrl":"https:\/\/octagamusa.com\/dermatomyositis\/wp-content\/uploads\/sites\/4\/2022\/05\/SocialShare_1200x630_10.jpg","width":1200,"height":630,"caption":"Octagam (Immune Globulin Intravenous [Human] 10% Liquid Preparation)"},"image":{"@id":"https:\/\/octagamusa.com\/dermatomyositis\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/pages\/356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/comments?post=356"}],"version-history":[{"count":0,"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/pages\/356\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/pages\/357"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/media\/505"}],"wp:attachment":[{"href":"https:\/\/octagamusa.com\/dermatomyositis\/wp-json\/wp\/v2\/media?parent=356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}